Ładuje się......
SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
Cisplatin and other platinum-based compounds are frequently used to treat breast cancer, but their utility is severely compromised by drug resistance. Many genes dictating drug responsiveness are subject to pre-mRNA alternative splicing which is regulated by key kinases such as the serine-arginine p...
Zapisane w:
| Wydane w: | Commun Biol |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group UK
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253463/ https://ncbi.nlm.nih.gov/pubmed/32461560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-0983-4 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|